4.4 Article

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Journal

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
Volume -, Issue 73, Pages -

Publisher

JOURNAL OF VISUALIZED EXPERIMENTS
DOI: 10.3791/50088

Keywords

Cancer Biology; Issue 73; Medicine; Molecular Biology; Cellular Biology; Biomedical Engineering; Genetics; Oncology; Pharmacology; Surgery; Tumor Microenvironment; Intravital imaging; chemotherapy; Breast cancer; time-lapse; mouse models; cancer cell death; stromal cell migration; cancer; imaging; transgenic; animal model

Funding

  1. National Cancer Institute [U01 CA141451]
  2. Starr Cancer Consortium
  3. Susan G. Komen for the Cure
  4. Long Island 2 Day Walk to Fight Breast Cancer
  5. Manhasset Women's Coalition Against Breast Cancer
  6. Congressionally Directed Breast Cancer Research Program, U.S.
  7. Leslie C. Quick and William Randolph Hearst Foundation Fellowships from the Watson School of Biological Sciences
  8. Research Council of Norway [160698/V40, 151882]
  9. Southeastern Regional Health Authorities [2007060]

Ask authors/readers for more resources

The tumor microenvironment plays a pivotal role in tumor initiation, progression, metastasis, and the response to anti-cancer therapies. Three-dimensional co-culture systems are frequently used to explicate tumor-stroma interactions, including their role in drug responses. However, many of the interactions that occur in vivo in the intact microenvironment cannot be completely replicated in these in vitro settings. Thus, direct visualization of these processes in real-time has become an important tool in understanding tumor responses to therapies and identifying the interactions between cancer cells and the stroma that can influence these responses. Here we provide a method for using spinning disk confocal microscopy of live, anesthetized mice to directly observe drug distribution, cancer cell responses and changes in tumor-stroma interactions following administration of systemic therapy in breast cancer models. We describe procedures for labeling different tumor components, treatment of animals for observing therapeutic responses, and the surgical procedure for exposing tumor tissues for imaging up to 40 hours. The results obtained from this protocol are time-lapse movies, in which such processes as drug infiltration, cancer cell death and stromal cell migration can be evaluated using image analysis software.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Zena Werb (1945-2020): Matrix Metalloproteinases, Microenvironments, and Mentoring

Mikala Egeblad

Summary: Dr. Zena Werb, a prominent faculty member at UCSF for over 40 years, was well-known for her discoveries in matrix metalloproteinases and their impact on development and disease. Her work significantly contributed to the understanding of the tumor microenvironment, making her a thought leader in the field and mentor to many researchers.

ANNUAL REVIEW OF CANCER BIOLOGY, VOL 5, 2021 (2021)

Article Oncology

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

P. Grivas, A. R. Khaki, T. M. Wise-Draper, B. French, C. Hennessy, C-Y Hsu, Y. Shyr, X. Li, T. K. Choueiri, C. A. Painter, S. Peters, B. Rini, M. A. Thompson, S. Mishra, D. R. Rivera, J. D. Acoba, M. Z. Abidi, Z. Bakouny, B. Bashir, T. Bekaii-Saab, S. Berg, E. H. Bernicker, M. A. Bilen, P. Bindal, R. Bishnoi, N. Bouganim, D. W. Bowles, A. Cabal, P. F. Caimi, D. D. Chism, J. Crowell, C. Curran, A. Desai, B. Dixon, D. B. Doroshow, E. B. Durbin, A. Elkrief, D. Farmakiotis, A. Fazio, L. A. Fecher, D. B. Flora, C. R. Friese, J. Fu, S. M. Gadgeel, M. D. Galsky, D. M. Gill, M. J. Glover, S. Goyal, P. Grover, S. Gulati, S. Gupta, S. Halabi, T. R. Halfdanarson, B. Halmos, D. J. Hausrath, J. E. Hawley, E. Hsu, M. Huynh-Le, C. Hwang, C. Jani, A. Jayaraj, D. B. Johnson, A. Kasi, H. Khan, V. S. Koshkin, N. M. Kuderer, D. H. Kwon, P. E. Lammers, A. Li, A. Loaiza-Bonilla, C. A. Low, M. B. Lustberg, G. H. Lyman, R. R. McKay, C. McNair, H. Menon, R. A. Mesa, V Mico, D. Mundt, G. Nagaraj, E. S. Nakasone, J. Nakayama, A. Nizam, N. L. Nock, C. Park, J. M. Patel, K. G. Patel, P. Peddi, N. A. Pennell, A. J. Piper-Vallillo, M. Puc, D. Ravindranathan, M. E. Reeves, D. Y. Reuben, L. Rosenstein, R. P. Rosovsky, S. M. Rubinstein, M. Salazar, A. L. Schmidt, G. K. Schwartz, M. R. Shah, S. A. Shah, C. Shah, J. A. Shaya, S. R. K. Singh, M. Smits, K. E. Stockerl-Goldstein, D. G. Stover, M. Streckfuss, S. Subbiah, L. Tachiki, E. Tadesse, A. Thakkar, M. D. Tucker, A. K. Verma, D. C. Vinh, M. Weiss, J. T. Wu, E. Wulff-Burchfield, Z. Xie, P. P. Yu, T. Zhang, A. Y. Zhou, H. Zhu, L. Zubiri, D. P. Shah, J. L. Warner, GdL Lopes

Summary: This study analyzed clinical factors and laboratory measurements of cancer patients with COVID-19, finding that factors such as age, sex, comorbidities, cancer type, and laboratory results were associated with COVID-19 severity. Patients diagnosed early in the pandemic had worse outcomes, and specific anticancer therapies may increase 30-day all-cause mortality. More research is needed to confirm these findings and caution may be needed in using certain anticancer treatments.

ANNALS OF ONCOLOGY (2021)

Meeting Abstract Oncology

Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis.

Elizabeth Trice Loggers, Elizabeth Marie Wulff-Burchfield, Ishwaria Mohan Subbiah, Ali Raza Khaki, Pamela Egan, Dimitrios Farmakiotis, Hardeep Phull, Elizabeth Nakasone, Chris Labaki, Peter Paul Yu, Monika Joshi, Elizabeth A. Griffiths, Trisha Michel Wise-Draper, Chinmay Jani, Astha Thakkar, Matthew Puc, Clara Hwang, Blanche H. Mavromatis, Dimpy P. Shah, Jeremy Lyle Warner

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Chemistry, Multidisciplinary

A Bivalent Activatable Fluorescent Probe for Screening and Intravital Imaging of Chemotherapy-Induced Cancer Cell Death

Nicole D. Barth, Lorena Mendive-Tapia, Ramon Subiros-Funosas, Ouldouz Ghashghaei, Rodolfo Lavilla, Laura Maiorino, Xue-Yan He, Ian Dransfield, Mikala Egeblad, Marc Vendrell

Summary: The study describes the design and optimization of a fluorescent probe, Apotracker Red, for real-time detection of cancer cell death. The probe exhibits strong fluorogenic behavior, high selectivity, and excellent stability, making it a reliable optical reporter for characterizing the effects of anticancer drugs in cells in vitro and for direct imaging of chemotherapy-induced apoptosis in vivo in mouse models of breast cancer.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Review Pathology

Innate Immunity and Cancer Pathophysiology

Laura Maiorino, Juliane Dassler-Plenker, Lijuan Sun, Mikala Egeblad

Summary: Chronic inflammation increases the risk of various cancers, while tumors themselves can trigger an inflammatory response. Inflammation can directly impact tumor growth and influence adaptive immune responses. Innate immune cells exhibit heterogeneity and plasticity, with variable phenotypes depending on tumor type, stage, and treatment options.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)

Article Multidisciplinary Sciences

Longitudinal Intravital Imaging Through Clear Silicone Windows

Laura Maiorino, Margaret Shevik, Jose M. Adrover, Xiao Han, Elias Georgas, John Erby Wilkinson, Harrison Seidner, Leonie Foerschner, David A. Tuveson, Yi-Xian Qin, Mikala Egeblad

Summary: Intravital microscopy (IVM) allows visualization of cell movement, division, and death at single-cell resolution. Thin film polydimethylsiloxane (PDMS) windows offer a simpler and less inflammatory alternative to traditional glass windows, allowing longitudinal imaging and tracking of the same tissue region using embedded grids.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2022)

Article Medicine, Research & Experimental

Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2

Jose M. Adrover, Lucia Carrau, Juliane Dassler-Plenker, Yaron Bram, Vasuretha Chandar, Sean Houghton, David Redmond, Joseph R. Merrill, Margaret Shevik, Benjamin R. TenOever, Scott K. Lyons, Robert E. Schwartz, Mikala Egeblad

Summary: Severe acute lung injury, characterized by high mortality and limited treatment options, can be improved with the use of disulfiram, an FDA-approved drug for alcohol use disorder. Disulfiram reduces neutrophil extracellular traps (NETs), improves survival and lung function in a mouse model of transfusion-related acute lung injury, and shows potential benefits in reducing NETs and inflammation in SARS-CoV-2-infected hamsters.

JCI INSIGHT (2022)

Review Oncology

Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer

Xue-Yan He, David Ng, Mikala Egeblad

Summary: The article introduces the roles of NETs in cancer, including promoting tumor growth, influencing immune escape, and promoting metastasis. It also discusses the potential clinical implications of targeting NETs as a novel therapeutic strategy for cancer.

ANNUAL REVIEW OF CANCER BIOLOGY (2022)

Review Immunology

Neutrophil phenotypes and functions in cancer: A consensus statement

Daniela F. Quail, Borko Amulic, Monowar Aziz, Betsy J. Barnes, Evgeniy Eruslanov, Zvi G. Fridlender, Helen S. Goodridge, Zvi Granot, Andres Hidalgo, Anna Huttenlocher, Mariana J. Kaplan, Ilaria Malanchi, Taha Merghoub, Etienne Meylan, Vivek Mittal, Mikael J. Pittet, Andrea Rubio-Ponce, Irina A. Udalova, Timo K. van den Berg, Denisa D. Wagner, Ping Wang, Arturo Zychlinsky, Karin E. de Visser, Mikala Egeblad, Paul Kubes

Summary: This article discusses the functional states and heterogeneity of neutrophils in cancer and provides a consensus statement on the controversies and solutions in neutrophil research. Further research is needed to understand the role of neutrophils in cancer and explore potential novel opportunities for cancer treatment.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Multidisciplinary Sciences

OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage

Xiaoli S. Wu, Xue-Yan He, Jonathan J. Ipsaro, Yu-Han Huang, Jonathan B. Preall, David Ng, Yan Ting Shue, Julien Sage, Mikala Egeblad, Leemor Joshua-Tor, Christopher R. Vakoc

Summary: Tuft cells are rare chemosensory cells that play a role in coordinating immune and neural responses to foreign pathogens. Recent studies have shown their involvement in small-cell lung cancer. This study reveals the critical role of POU2F3-OCA-T complex in tuft cell identity and its potential as a molecular vulnerability in small-cell lung cancer.

NATURE (2022)

Article Medicine, Research & Experimental

PTP1B inhibitors protect against acute lung injury and regulate CXCR4 signaling in neutrophils

Dongyan Song, Jose M. Adrover, Christy Felice, Lisa N. Christensen, Xue-Yan He, Joseph R. Merrill, John E. Wilkinson, Tobias Janowitz, Scott K. Lyons, Mikala Egeblad, Nicholas K. Tonks

Summary: PTP1B inhibitors have shown potential in preventing acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). These inhibitors can attenuate aberrant neutrophil function, inhibit neutrophil migration, and promote an aged-neutrophil phenotype by reducing signaling through the CXCR4 chemokine receptor. Additionally, PTP1B inhibitors have therapeutic effects in sepsis models.

JCI INSIGHT (2022)

Article Oncology

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

Michael J. Wagner, Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann, Diana Vilar-Compte, Erika Ruiz-Garcia, Matthew Ingham, Gary K. Schwartz, Corrie A. Painter, Rashmi Chugh, Leslie Fecher, Cathleen Park, Olga Zamulko, Jonathan C. Trent, Vivek Subbiah, Ali Raza Khaki, Lisa Tachiki, Elizabeth S. Nakasone, Elizabeth T. Loggers, Chris Labaki, Renee Maria Saliby, Rana R. McKay, Archana Ajmera, Elizabeth A. Griffiths, Igor Puzanov, William D. Tap, Clara Hwang, Sachin R. Jhawar, Brandon Hayes-Lattin, Elizabeth Wulff-Burchfield, Anup Kasi, Daniel Y. Reuben, Gayathri Nagaraj, Monika Joshi, Hyma Polimera, Amit A. Kulkarni, Khashayar Esfahani, Daniel H. Kwon, Luca Paoluzzi, Mehmet A. Bilen, Eric B. Durbin, Petros Grivas, Jeremy L. Warner, Elizabeth J. Davis

Summary: Patients with sarcoma have a higher risk of developing complications from COVID-19, and patients with bone sarcoma may be at a greater risk of death from COVID-19. Older age, poor performance status, and lung metastases are risk factors for more severe COVID-19.

CANCERS (2022)

Review Oncology

NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps

Jose M. Adrover, Sheri A. C. McDowell, Xue-Yan He, Daniela F. Quail, Mikala Egeblad

Summary: Neutrophils are key players in the immune system, involved in pathogen eradication and cancer progression. Cancer cells manipulate neutrophil biology, including the formation of neutrophil extracellular traps (NETs), to their advantage. This article discusses how cancer stimulates NET formation and how NETs contribute to disease progression. It also explores the link between neutrophils, NETs, vascular dysfunction, thrombosis, and increased cardiovascular risk in cancer patients. Therapeutic strategies targeting NETs in clinical settings are proposed.

CANCER CELL (2023)

Article Biochemical Research Methods

Isolation of mouse mammary carcinoma-derived macrophages and cancer cells for co-culture assays

Lijuan Sun, Xiao Han, Mikala Egeblad

Summary: An in vitro co-culture system was established using MPLA+IFNγ-treated TAMs to kill cancer cells. The technical challenge lies in isolating and staining TAMs and cancer cells from the same tumor.

STAR PROTOCOLS (2022)

Article Oncology

Treatment with Granulocyte-colony Stimulating Factor (G-CSF) is not associated with Increased Risk of Brain Metastasis in Patients with De Novo Stage IV Breast Cancer

Takeo Fujii, Hasan Rehman, Su Yun Chung, Janice Shen, James Newman, Vernon Wu, Adam Hines, Elham Azimi-Nekoo, Fatima Fayyaz, Meeyoung Lee, George Raptis, Mikala Egeblad, Xinhua Zhu

Summary: The study found that G-CSF use was not associated with an increased risk of brain metastasis in patients with de novo Stage IV breast cancer. However, pulmonary embolism/deep venous thrombosis may be related to brain metastasis. Further research is needed to determine if DVT/PE with or without elevated NETs levels in the blood can predict the development of brain metastasis in these patients.

JOURNAL OF CANCER (2021)

No Data Available